Nordic Life Science News: CARTANA’s In Situ Sequencing chosen as key enabling technology in European Horizon 2020 funded projects
29 January 2020
CARTANA has been featured on the Nordic Life Science News and was recognized as the key enabling technology in European Horizon 2020 funded projects. We are delighted to be the partner for half of the European funded HCA projects!
Podcast at King’s College London
16 October 2019
King’s College London has recently released a podcast with CARTANA. In this podcast, Ph.D. student Dr. Xinyi (Beibei) Du discuss Single-cell and Spatial Transcriptomics with our CEO and Co-founder, Dr. Malte Kühnemund.
SME Instrument Phase I
4 September 2019
CARTANA was awarded SME Instrument Phase I from Vinnova. The funding will be used for the improvement of the library preparation kit and to adapt it to be used in the application of oncology, especially immuno-oncology, as well as other areas.
CARTANA, Lunaphore and Stockholm University have started a collaboration on automated Next Generation In Situ Sequencing
10 June 2019
The collaboration aims at the integration and automation of CARTANA’s Next Generation In Situ Sequencing (NGISS) on Lunaphore’s microfluidic tissue processor technology that will greatly simplify in situ sequencing workflows in laboratories.
Innovative Start up Phase II Grant
8 October 2018
CARTANA was awarded Innovative Start up Phase II from Vinnova. The funding will be used for the development of the next generation of In Situ Sequencing.
CARTANA NEURO KIT
6 June 2018
CARTANA is proud to launch its first product, the NeuroKit. CARTANA’s NeuroKit is an optimized reagent kit that enables the mapping of hundreds of genes and cell types via In Situ Sequencing (ISS) in a single tissue section with high throughput and high sensitivity. Neuro kit.